These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2883661)
1. Inhibitory effects of somatostatin analogs on prolactin secretion in rats pretreated with estrogen or haloperidol. Karashima T; Schally AV Proc Soc Exp Biol Med; 1987 May; 185(1):69-75. PubMed ID: 2883661 [TBL] [Abstract][Full Text] [Related]
2. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release. Karashima T; Cai RZ; Schally AV Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886 [TBL] [Abstract][Full Text] [Related]
3. Superactive octapeptide somatostatin analogs containing tryptophan at position 1. Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520 [TBL] [Abstract][Full Text] [Related]
4. Comparison of somatostatin and its highly potent hexa- and octapeptide analogs on exocrine and endocrine pancreatic secretion. Konturek SJ; Bilski J; Jaworek J; Tasler J; Schally AV Proc Soc Exp Biol Med; 1988 Feb; 187(2):241-9. PubMed ID: 2448802 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of receptors for somatostatin in various tumors using different analogs. Srkalovic G; Cai RZ; Schally AV J Clin Endocrinol Metab; 1990 Mar; 70(3):661-9. PubMed ID: 1968467 [TBL] [Abstract][Full Text] [Related]
6. Effect of somatostatin analogs on gastric acid secretion in dogs and rats. Schally AV; Colaluca J; Paulson D; Carter WH; Neitzschman HR; Lafaye H; Cai RZ Int J Pept Protein Res; 1990 Sep; 36(3):267-74. PubMed ID: 1980670 [TBL] [Abstract][Full Text] [Related]
7. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer. Schally AV; Redding TW Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164 [TBL] [Abstract][Full Text] [Related]
8. Delayed release formulation of the somatostatin analog RC-160 inhibits the growth hormone (GH) response to GH-releasing factor-(1-29)NH2 and decreases elevated prolactin levels in rats. Bokser L; Schally AV Endocrinology; 1988 Oct; 123(4):1735-9. PubMed ID: 2901338 [TBL] [Abstract][Full Text] [Related]
9. Discovery of iodinated somatostatin analogues selective for hsst2 and hsst5 with excellent inhibition of growth hormone and prolactin release from rat pituitary cells. Moore SB; van der Hoek J; de Capua A; van Koetsveld PM; Hofland LJ; Lamberts SW; Goodman M J Med Chem; 2005 Oct; 48(21):6643-52. PubMed ID: 16220980 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of growth of a prolactin and growth hormone-secreting pituitary tumor in rats by D-tryptophan-6 analog of luteinizing hormone-releasing hormone. Torres-Aleman I; Redding TW; Schally AV Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1252-6. PubMed ID: 2858096 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin. Cai RZ; Szoke B; Lu R; Fu D; Redding TW; Schally AV Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1896-900. PubMed ID: 2869490 [TBL] [Abstract][Full Text] [Related]
12. Underfeeding-induced suppression of mammary tumors: counteraction by estrogen and haloperidol. ThyagaRajan S; Meites J; Quadri SK Proc Soc Exp Biol Med; 1993 Jun; 203(2):236-42. PubMed ID: 7684845 [TBL] [Abstract][Full Text] [Related]
13. Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells. Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Lamberts SW Endocrinology; 1994 Jan; 134(1):301-6. PubMed ID: 7903931 [TBL] [Abstract][Full Text] [Related]
14. Somatostatin inhibits prolactin secretion in the estradiol primed male rat. Cooper GR; Shin SH Can J Physiol Pharmacol; 1981 Oct; 59(10):1082-8. PubMed ID: 6119146 [TBL] [Abstract][Full Text] [Related]
15. Superactive somatostatin analog decreases plasma glucose and glucagon levels in diabetic rats. Karashima T; Schally AV Peptides; 1988; 9(3):561-5. PubMed ID: 2901737 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone and prolactin secretion in hypophysial stalk-transected pigs as affected by growth hormone and prolactin-releasing and inhibiting factors. Anderson LL; Ford JJ; Klindt J; Molina JR; Vale WW; Rivier J Proc Soc Exp Biol Med; 1991 Feb; 196(2):194-202. PubMed ID: 1671298 [TBL] [Abstract][Full Text] [Related]
17. Correlation of rat pituitary prolactin messenger ribonucleic acid and hormone content with serum levels during the estrogen-induced surge. Carrillo AJ; Sharp ZD; DePaolo LV Endocrinology; 1987 Dec; 121(6):1993-9. PubMed ID: 3678136 [TBL] [Abstract][Full Text] [Related]
18. The effect of the somatostatin analog SMS 201-995 on normal growth hormone secretion in the rat. A comparison with the effect of bromocriptine on normal prolactin secretion. Lamberts SW; Verleun T; Zuiderwijk JM; Oosterom R Acta Endocrinol (Copenh); 1987 Jun; 115(2):196-202. PubMed ID: 2885995 [TBL] [Abstract][Full Text] [Related]
19. Effect of estrogen on the growth hormone (GH) secretory response to GH-releasing factor in the castrate adult female rat in vivo. Shulman DI; Sweetland M; Duckett G; Root AW Endocrinology; 1987 Mar; 120(3):1047-51. PubMed ID: 3100282 [TBL] [Abstract][Full Text] [Related]
20. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens. Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]